Trial intelligence / Profile preview

Boceprevir in Acute HCV Genotype 1 with HIV Co-infection

NCT01912495Phase 2Completed

Sponsor
Erasmus MC
Start
Aug 2013
Primary completion
Aug 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of boceprevir in hepatitis C virus infection, sponsored by Erasmus MC. Started Aug 2013; status: completed.

02

Drugs

boceprevir
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NCT01912495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01912495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call